|
509 New
pharmaceutical care model schemes covering asthma and epilepsy announced
for Scotland Two new pharmaceutical care model schemes (PCMS)
are to be introduced in Scotland for asthma and epilepsy ...more
509 Essential
small pharmacies scheme to end The Essential Small Pharmacies
Scheme, which has for many years sustained predominantly rural pharmacies
in England and Wales that would otherwise be unviable, is to come to
an end ...more
509 Call
to annotate Register for administrators The Royal Pharmaceutical
Society’s Register of pharmacists should include a separate
classification for administrative pharmacists, say members of the Association
of Independent Multiple Pharmacies (AIMp) ...more
509 HRT
increases womb cancer Postmenopausal women taking oestrogen-only
hormone replacement therapy or tibolone have a greater risk of endometrial
cancer than those taking combination HRT, say researchers. However, they
note that since the risk of breast cancer is greater with combination
HRT, total cancer incidence remains higher for combined HRT ...more
509 New
chairman for NPA board Rajesh (Raj) Patel, a community pharmacist from Cheshire, has this week been elected chairman of the National Pharmaceutical Association for 2005–06 ...more
510 Election
brings opportunities to promote pharmacy Key pharmacy bodies
have been taking the opportunity to promote the profession during the
run-up to the general election ...more
510 New
health Bill in Scotland takes a step forwards Legislation required for the new community pharmacy contract in Scotland moved closer to reality last week when the Scottish Executive’s health committee announced its support for the Smoking, Health and Social Care (Scotland) Bill. The Bill will also result in strengthened disciplinary powers for the NHS over pharmacists who provide pharmaceutical care
...more
510 New
contract worries for NPA The National Pharmaceutical Association
is worried that pharmacy owners will be confused by a revised monthly
reporting form that has been introduced with the new pharmacy contract
...more
510 Changes
to generics reimbursement in Scotland Changes to the reimbursement
of drugs in part 7 of the Scottish Drug Tariff were announced this week
...more
510 Increased
fee for flu vaccine Community pharmacists in Scotland will
be paid a two-tier professional fee for supplying influenza vaccines
to GPs this year ...more
|
511 Evidence
grows for pharmacist input in diabetes care Further evidence
that pharmacists’ interventions improve glycaemic control in patients
with type 2 diabetes was presented at the Diabetes UK annual professional
conference in Glasgow last week ...more
511 EMEA completes
review of SSRIs and recommends wider product warning Selective
serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors
should not be used in children and adolescents except for their approved
indications, the European Medicines Agency (EMEA) has concluded following
its review of the antidepressants ...more
511 Booklets
for patients with learning disabilities Three new booklets
to help people with learning disabilities make informed decisions about
their medicines were launched this week by Medicines Partnership and
the Norah Fry Research Centre ...more
511 AAH new contract
resource pack and CD-ROM launched AAH Pharmaceuticals has
launched a resource pack to help its customers in England and Wales implement
the new community pharmacy contract ...more
512 Modafinil
fails to improve fatigue Modafinil, a drug used to treat daytime
sleepiness, does not appear to improve fatigue in patients with multiple
sclerosis, a trial has revealed. Aspirin, on the other hand, may reduce
the severity of this symptom ...more
512 Calcium and
vitamin D3 supplements do not prevent fractures Supplementation
with calcium and vitamin D3, either alone or in combination, is not effective
in the prevention of fractures in elderly people, according to two new
UK studies ...more
512 Rosuvastatin
reduces plaque size and changes composition Impact of rosuvastatin
(Crestor) on the size and composition of atherosclerotic plaques in the
carotid arteries has been shown by magnetic resonance imaging in the
first trial of its kind. Data from the study were presented by AstraZeneca
in London last week ...more
|
The
Pharmaceutical Journal